Background & aims Apolipoproteins and lipoprotein (a) are associated with various
cardiometabolic diseases, including insulin resistance, diabetes mellitus, hypertension …

Lowered high-density lipoprotein (HDL) cholesterol has been reported in major depressive
disorder, bipolar disorder, first episode of psychosis, and schizophrenia. HDL, its major …

Schizophrenia is a devastating psychiatric illness that detrimentally affects a significant
portion of the worldwide population. Aging of schizophrenia patients is associated with …

Apolipoprotein A-II (apoA-II) is the second most abundant apolipoprotein in high-density
lipoprotein (HDL) particles, playing an important role in lipid metabolism. Human and murine …

Mass spectrometry (MS)-based techniques can be a powerful tool to identify
neuropsychiatric disorder biomarkers, improving prediction and diagnosis ability. Here, we …

Introduction Obesity has been historically associated with nonalcoholic fatty liver disease
(NAFLD), but it can also occur in lean individuals. However, limited data is available on this …

The conventional differentiation of affective disorders into major depressive disorder (MDD)
and bipolar disorder (BD) has insufficient biological evidence. Utilizing multiple proteins …

Metabolic syndrome (MetS) is a clustering of at least three of the following five medical
conditions: abdominal obesity, high blood pressure, high blood sugar, high serum …

Background: Metabolic syndrome is widespread in patients with schizophrenia receiving
long-term antipsychotic therapy. Dopamine D2 receptors play an important role in mediating …

The adipokines leptin, adiponectin, tumor necrosis factor-alpha (TNF-α), and interleukin 6 (IL-
6) might be associated with metabolic syndrome (MetS) in patients with schizophrenia. In the …